Inverse relations
[ .. ] → wdt:P4844 → cholecalciferol
25-Hydroxyvitamin D Pharmacokinetic Study
4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)
A Clinical Trial to Evaluate the Safety and Pharmacokinetic
A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
A Prospective, Single-centre, Open-label Study to Confirm the Efficacy and Safety of Vitamin D3 B.O.N. Intramuscular Injection in Adults With Vitamin D Deficiency
A Study on Oral Vitamin D Megadoses
A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)
A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)
AK-R215 Pharmacokinetic Study Phase I
Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
Association Between Vitamin D and the Risk of Uterine Fibroids
Calcium (ca),Phosphorus( P) and 25-hydroxyvitamin D(25OHD)] in Infants Born ≤ 32 PMA Gestational Weeks (GA)
Calcium + Vitamin D Supplementation for Low Bone Mass in Adolescent Idiopathic Scoliosis (AIS)
Can Vitamin D Supplementation in People With Crohn's Disease Improve Symptoms as an Adjunct Therapy?
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Changes in Serum Vitamin D Level After Different Loading Doses of Cholecalciferol
Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) Subjects
Cholecalciferol and Flu Vaccine in Treating Healthy Participants
Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy
... show all 284
[ .. ] → wdt:P527 → cholecalciferol
Biochemical pathways: part I
CYP2R1 25-hydroxylates VD3 to 25(OH)D
Defective CYP2R1 does not 25-hydroxylate vitamin D
GC:VD3 [extracellular region]
Retinol metabolism
VD3 binds GC
VD3 dissociates from GC
Vitamin D-sensitive calcium signaling in depression
Vitamins A and D - action mechanisms
... show all 26